Is a complete NSPR research report available?

No complete published report is available for InspireMD, Inc. (NSPR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

InspireMD, Inc. (NSPR)

NASDAQ: NSPR · USD

$0.68

-0.01 (-1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NSPR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	32M
Revenue (ttm)	10.8M
Net income (ttm)	-51.3M
EPS (ttm)	-$0.71
Shares out	46.8M
Volume	15,575.662
Beta	0.78
Price target	$3.67	+436.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.8M
Net income (ttm): -51.3M
EPS (ttm): -$0.71
Market cap: 32M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NSPR indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001433607
Company name	InspireMD, Inc.
Country	United States
Country code	US
Cusip	45779A846
Employees	127
Employees Change	41%
Employees Change Percent	47.67
Enterprise value	$-6.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.89
Industry PE Fwd	18.91
Isin	US45779A8466
Last refreshed	2026-07-26
Market cap	$32M
Market cap category	Nano-Cap
Price	$0.68
Price currency	USD
Rev Per Employee	85,417.32x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	3841
Symbol	NSPR
Website	https://www.inspiremd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-160.25%
FCF yield	-125.38%
P/B ratio	0.73x
P/S ratio	2.95x
PS Forward	2.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-480.57%
EBITDA Margin	-475.71%
Gross margin	28.06%
Gross Profit	$3M
Gross Profit Growth	102.12%
Gross Profit Growth Q	135.27%
Gross Profit Growth3 Y	30.55%
Net Income	$-51.3M
Net Income Growth Years	0%
Pretax Margin	-472.4%
Profit Per Employee	$-404,008
ROA	-68.49
Roa5y	-40.52
ROCE	-110.9
ROE	-142.6
Roe5y	-79.9
ROIC	-84.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-70.66%
Cagr15y	-70.59%
Cagr1y	-72.46%
Cagr3y	-40.7%
Cagr5y	-30.87%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	54.38x
Revenue Growth Q	122.24x
Revenue Growth Quarters	13x
Revenue Growth Years	5x
Revenue Growth3 Y	27.56x
Revenue Growth5 Y	34.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.23
Assets	$56.5M
Cash	$41.6M
Current Assets	$48.6M
Current Liabilities	$9.4M
Debt	$3.1M
Debt Equity	$0.07
Equity	$43.6M
Liabilities	$12.9M
Long Term Assets	$7.9M
Long Term Liabilities	$3.4M
Net Cash	$38.5M
Net Cash By Market Cap	$120
Net Cash Growth	61.85%
Net Debt Equity	$-0.88
Tangible Book Value	$43.6M
Tangible Book Value Per Share	$0.93
WACC	7.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.15
Inventory Turnover	2.66
Net Working Capital	$-1.4M
Quick ratio	4.7
Working Capital	$39.2M
Working Capital Turnover	$0.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-58.68%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-72.44%
200-day SMA	1.53
3Y total return	-79.16%
50-day SMA	0.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.21%
All Time High	75,853,018.4
All Time High Change	-100%
All Time High Date	2011-06-01
All Time Low	0.63
All Time Low Change	8.5%
All Time Low Date	2026-06-26
ATR	0.04
Beta	0.78
Beta1y	-0.13
Beta2y	-0.28
Ch YTD	-61.6
High	0.69
High52	2.93
High52 Date	2025-08-04
High52ch	-76.69%
Low	0.68
Low52	0.63
Low52 Date	2026-06-26
Low52ch	8.5%
Ma50ch	-15.48%
Price vs 200-day SMA	-55.23%
RSI	36.18
RSI Monthly	32.25
RSI Weekly	20.51
Sharpe ratio	-1.94x
Sortino ratio	-2.57
Total Return	-58.68%
Tr YTD	-61.6
Tr15y	-100%
Tr1m	-2.49%
Tr1w	-2.57%
Tr3m	-46.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$3
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.2
Earnings Revenue Estimate	1,436,400x
Earnings Revenue Estimate Growth	-19.21x
Operating Income	$-52.1M
Operating margin	-480.6
Price target	$3.67
Price Target Change	$437
Price Target Change Top	$339

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,293,392%
Float Percent	56.14%
Shares Insiders	16.47%
Shares Institutions	22.24%
Shares Out	46,838,962
Shares Qo Q	1.74%
Shares Yo Y	58.68%
Short Float	0.28%
Short Ratio	0.53
Short Shares	0.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-51.9M
Average Volume	61,351.95x
Bv Per Share	0.93
CAPEX	$-1.5M
Ch10y	-100
Ch15y	-100
Ch1m	-2.49
Ch1w	-2.57
Ch1y	-72.44
Ch3m	-46.6
Ch3y	-79.16
Ch5y	-84.21
Ch6m	-57.8
Change	-1.63%
Change From Open	-1.63
Close	0.69
Days Gap	0
Depreciation Amortization	527,000
Dollar Volume	10,647
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-52.1M
EBITDA	$-51.6M
EPS	$-0.71
F Score	4
FCF	$-40.1M
FCF EV Yield	623.02x
FCF Per Share	$-0.86
Financing CF	55,063,000
Fiscal Year End	December
Founded	2,005
Income Tax	$63,000
Investing CF	-17,483,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Date	2021-04-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-18
Ma150	1.34
Ma150ch	-49.1%
Ma20	0.7
Ma20ch	-2.89%
Net CF	-1,021,000
Next Earnings Date	2026-08-07
Open	0.69
Optionable	Yes
Position In Range	8.58
Post Close	0.68
Postmarket Change Percent	-0.52
Postmarket Price	$0.68
Ppne	6,246,000
Price Date	2026-07-24
Ptbv Ratio	0.73
Relative Volume	0.25x
Revenue	10,848,000x
SBC By Revenue	107.93x
Share Based Comp	11,708,000
Tax By Revenue	0.58x
Tr6m	-57.8%
Us State	Florida
Volume	15,575.7
Z Score	-6.01

InspireMD, Inc. (NSPR)

Coverage state: Market snapshot only — no published research

Generate the first NSPR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NSPR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSPR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSPR

Frequently asked questions